EGR1

From WikiMD's WELLNESSPEDIA

EGR1 (Early Growth Response 1) is a protein that in humans is encoded by the EGR1 gene. It is also known as Zif268 (zinc finger protein 224), NGFI-A (nerve growth factor-induced protein A), and Krox-24, among other names. EGR1 is a transcription factor with three zinc finger domains that bind to DNA and function in the regulation of cellular growth and differentiation.

Function[edit]

EGR1 is a transcription factor that is activated in response to growth factors and stress. It is involved in a variety of biological processes, including cell proliferation, differentiation, apoptosis, and neoplastic transformation. EGR1 can also stimulate expression of target genes, which can influence the growth and development of many types of cells in the body.

Clinical significance[edit]

Alterations in EGR1 expression have been associated with various diseases, including cancer, schizophrenia, Alzheimer's disease, and ischemic injury. In cancer, EGR1 can function as a tumor suppressor or an oncogene, depending on the context. In neurological disorders like schizophrenia and Alzheimer's, changes in EGR1 expression may contribute to disease pathology.

Research[edit]

Research on EGR1 has focused on its role in cell growth and differentiation, as well as its potential as a therapeutic target in cancer and neurological disorders. Studies have also investigated the regulation of EGR1 expression and its interaction with other proteins and genes.

See also[edit]

References[edit]


External links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.